Clinical Trial Highlights

• ARCHER 1009 Subset Analysis and LUX-8 Lung: Erlotinib Compared With Dacomitinib or Afatinib
• Gemcitabine Switch Maintenance Superior to Supportive Care in Advanced NSCLC
• ASSESS
• Hints of Better Survival With Surgery Than Radiation Therapy in Stage I NSCLC
• Diffusion-Weighted Imaging
• ESTERN
• Veliparib Plus Platinum Therapy Promising in NSCLC Phase 2 Trial
• TIME Trial
• LUX-Lung 5
• Age-Stratified Subgroup Analysis of SQUIRE in Patients With Stage IV Squamous NSCLC
• Novel Compound Beneficial as Adjunct to Antibody-Based Therapy for Stage IV NSCLC Patients
• ALTER0302
• Prognostic Factors Identified in Stage IV NSCLC
• Platinum-Plus Regimens Equally Effective First Therapies for EGFR Wild-Type NSCLC
• SBRT as Effective Treatment Option for Medically Operable Stage I NSCLC